The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Receptor-Dependent Mechanisms of Cell Stimulation by Bacterial Endotoxin
Abstract
In humans and experimental animals the presence of bacterial lipopolysaccharide (endotoxin, LPS) signals the presence of gram-negative bacteria. Recognition of LPS triggers gene induction by myeloid and nonmyeloid lineage cells. These inducible genes encode proteins that include cytokines, adhesive proteins, and enzymes that produce low molecular weight proinflammatory mediators. Together the products of these inducible genes upregulate host defense systems that participate in eliminating the bacterial infection. Unfortunately, these same mediators contribute to a serious human disease known as septic shock. Considerable progress has been made during the past decade in determining the sources, identities, and sequence of release of these mediators. In contrast, until recently, marked gaps in our knowledge existed regarding the identity of the LPS receptor and intracellular signaling pathways responsible for LPS-induced cell activation. The discovery in 1986 of a plasma protein termed LPS binding protein (LBP) led to the discovery of unanticipated mechanisms of LPS-induced cell activation. CD14 was found as a soluble serum protein or as a glycosylphosphatidylinositol (GPI)-anchored protein of myeloid lineage cells; it now occupies a key role in LPS-induced cell activation as we understand it today. Here we discuss how LBP enables LPS binding to CD14 and how complexes of LPS and soluble or GPI-anchored CD14 participate in cell activation. We also review the evidence supporting a model for a functional LPS receptor of myeloid cells, which is multimeric, comprised of GPI-anchored CD14 and a presently unidentified transmembrane protein that together bind LPS and initiate cell activation via kinase cascades.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“bacterial cell wall lipopolysaccharides (LPS) induce synthesis of IL-18.20”
From The Gut Microbiome and the Brain (2014) · cites this paper as [20]
Citations
Cites
A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J. D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,647
Self-citationStructure and Function of Lipopolysaccharide Binding Protein
Schumann, R. R., Leong, S. R., Flaggs, G., Gray, P. W., Wright, S. D., Mathison, J. C., Tobias, P. S., & Ulevitch, R. J. (1990) · Science · doi:10.1126/science.2402637 · Cited by 1,672
Self-citationThe immune system evolved to discriminate infectious nonself from noninfectious self
Janeway, C. A. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90198-g · Cited by 1,343
Takeda, J., Miyata, T., Kawagoe, K., Iida, Y., Endo, Y., Fujita, T., Takahashi, M., Kitani, T., & Kinoshita, T. (1993) · Cell · doi:10.1016/0092-8674(93)90250-t · Cited by 1,059
A Divergence in the MAP Kinase Regulatory Network Defined by MEK Kinase and Raf
Lange-Carter, C. A., Pleiman, C. M., Gardner, A. M., Blumer, K. J., & Johnson, G. L. (1993) · Science · doi:10.1126/science.8385802 · Cited by 827
Potocytosis: Sequestration and Transport of Small Molecules by Caveolae
Anderson, R. G. W., Kamen, B. A., Rothberg, K. G., & Lacey, S. W. (1992) · Science · doi:10.1126/science.1310359 · Cited by 734
Haziot, A., Chen, S., Ferrero, E., Low, M. G., Silber, R., & Goyert, S. M. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.2.547 · Cited by 645
Atomic structure of the MAP kinase ERK2 at 2.3 A resolution
Zhang, F., Strand, A., Robbins, D., Cobb, M. H., & Goldsmith, E. J. (1994) · Nature · doi:10.1038/367704a0 · Cited by 592
Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum.
Tobias, P. S., Soldau, K., & Ulevitch, R. J. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.164.3.777 · Cited by 547
Self-citationRaetz, C. R. H., Ulevitch, R. I., Wright, S. D., Sibley, C. H., Ding, A. H., & Nathan, C. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.12.1916089 · Cited by 507
Self-citation
Cited by
Sorted by citations
Items 401–500 of 1,000
Evolutionary perspective on innate immune recognition
Mushegian, A. R., & Medzhitov, R. M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200107040 · Cited by 89
“MD2 is a small protein that lacks a transmembrane region, but is associated with the extracellular domain of TLR4 (Shimazu et al., 1999) and has been shown to be required for LPS recognition by TLR4 (Schromm et al., 2001).”
BackgroundIn Vitro Thrombogenicity Testing of Biomaterials
Braune, S., Latour, R. A., Reinthaler, M., Landmesser, U., Lendlein, A., & Jung, F. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201900527 · Cited by 87
Vamadevan, A. S., Fukata, M., Arnold, E. T., Thomas, L. S., Hsu, D. S., & Abreu, M. T. (2009) · Innate Immunity · doi:10.1177/1753425909339231 · Cited by 94
“Recognition of LPS begins with its transfer to CD14 via the opsonin LPS-binding protein.(22,23) The LPS/CD14 interaction stimulates the pattern recognition receptor TLR4, the sole sensor for LPS, via MD-2-mediated recognition of LPS and activation of TLR4.”
BackgroundSobek, V., Birkner, N., Falk, I. J., Würch, A., Kirschning, C. J., Wagner, H., Wallich, R., Lamers, M. C., & Simon, M. M. (2004) · Arthritis Research & Therapy · doi:10.1186/ar1212 · Cited by 86
“Optimal signaling by LPS requires, besides TLR-4, several accessory molecules such as LBP, MD-2 and CD14 [47,48].”
BackgroundGao, J., Xue, Q., Papasian, C. J., & Morrison, D. C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6855 · Cited by 86
Li, X., Udagawa, N., Takami, M., Sato, N., Kobayashi, Y., & Takahashi, N. (2003) · Endocrinology · doi:10.1210/en.2003-0166 · Cited by 85
The adaptor protein shc is involved in the negative regulation of NK cell-mediated cytotoxicity
Galandrini, R., Tassi, I., Morrone, S., Lanfrancone, L., Pelicci, P. G., Piccoli, M., Frati, L., & Santoni, A. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200107)31:7 · Cited by 32
CD14 and lipopolysaccharide binding protein expression in a rat model of alcoholic liver disease.
Su, G. L., Rahemtulla, A., Thomas, P., Klein, R. D., Wang, S. C., & Nanji, A. A. (1998) · Europe PMC (PubMed Central) · Cited by 85
LPS-Induced Galectin-3 Oligomerization Results in Enhancement of Neutrophil Activation
Fermino, M. L., Polli, C. D., Toledo, K. A., Liu, F., Hsu, D. K., Roque‐Barreira, M. C., Pereira-da-Silva, G., Bernardes, E. S., & Halbwachs‐Mecarelli, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026004 · Cited by 84
“Lipopolysaccharide (LPS) represents a major pathogen-associated molecular pattern (PAMP) from the outer membrane of Gram-negative bacteria and is a potent immune activator closely associated with many infectious and inflammatory diseases [1,2].”
5. Genetics of hypersensitivity
Steinke, J. W., Borish, L., & Rosenwasser, L. J. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.143 · Cited by 84
“Engagement of CD14 is associated with strong IL-12 responses in antigen-presenting cells and is a necessary signal in the formation of Th1 cells from naive T cells [ 14 ].”
BackgroundOhnishi, T., Muroi, M., & Tanamoto, K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3354 · Cited by 83
“L ipopolysaccharide is a component of the outer membrane of Gram-negative bacteria and activates a variety of cells, including monocytes and macrophages (1, 2).”
BackgroundIshida, I., Kubo, H., Suzuki, S., Suzuki, T., Akashi, S., Inoue, K., Maeda, S., Kikuchi, H., Sasaki, H., & Kondo, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.2069 · Cited by 85
“LPS induces a severe inflammatory response by initiating multiple intracellular signaling events, including the activation of NF- B, which ultimately leads to the synthesis and release of many proinflammatory mediators and adhesion molecules, such as IL-1, IL-6, IL-8, TNF- , and ICAM-1 (3, 4).”
BackgroundInfluentialBoddeke, E., Meigel, I., Frentzel, S., Biber, K. P. H., Renn, L. Q., & Gebicke‐Haerter, P. J. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00307-6 · Cited by 84
Lim, J. H., Jono, H., Koga, T., Woo, C.-H., Ishinaga, H., Bourne, P. A., Xu, H., Ha, U., Xu, H., & Li, J. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001032 · Cited by 82
“Although the inflammatory response triggered by bacteria is essential for eradicating bacterial pathogen, excessive inflammatory response is clearly detrimental to the host, due to severe tissue damage [11,12].”
BackgroundOverexpression of cardiac I-κBα prevents endotoxin-induced myocardial dysfunction
Haudek, S. B., Spencer, E., Bryant, D. D., White, D. J., Maass, D. L., Horton, J. W., Chen, Z. J., & Giroir, B. P. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.3.h962 · Cited by 83
“Compelling genetic data now suggest that TLR4, acting in conjunction with the secreted protein MD-2, is the sole LPS receptor (3, 37).”
BackgroundInfluentialSellati, T. J., Bouis, D. A., Caimano, M. J., Feulner, J. A., Ayers, C., Lien, E., & Radolf, J. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.2049 · Cited by 83
Lorenz, W., Buhrmann, C., Mobasheri, A., Lueders, C., & Shakibaei, M. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4291 · Cited by 82
“LPS-induced signaling is thought to begin with its binding to specific surface receptors such as Toll-like receptor 4 (TLR4), which trigger intracellular signaling cascades leading to activation of the multiple proinflammatory signaling pathways [16,17].”
BackgroundSha, J., Fadl, A. A., Klimpel, G. R., Niesel, D. W., Popov, V. L., & Chopra, A. K. (2004) · Infection and Immunity · doi:10.1128/iai.72.7.3987-4003.2004 · Cited by 82
Martin, A. C., Laing, I. A., Khoo, S., Zhang, G., Rueter, K., Teoh, L., Taheri, S., Hayden, C. M., Geelhoed, G. C., Goldblatt, J., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1367oc · Cited by 82
“It is expressed on monocytes and macrophages, functions as a receptor for LPS ( 13 ), and exists in a membrane-bound form and a soluble form (sCD14).”
BackgroundMuroi, M., & Tanamoto, K. (2002) · Infection and Immunity · doi:10.1128/iai.70.11.6043-6047.2002 · Cited by 83
“Bacterial lipopolysaccharide (LPS) is a constituent of the outer membrane of the cell wall of gram-negative bacteria and plays a major role in septic shock in humans (25, 30).”
BackgroundNordgreen, J., Munsterhjelm, C., Aae, F., Popova, A., Boysen, P., Ranheim, B., Heinonen, M., Raszplewicz, J., Piepponen, P. T., Lervik, A., et al. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.07.013 · Cited by 84
“The activation of these transcription factors increases the production of pro-inflammatory cytokines, stimulates the production of acute phase proteins in the liver, and activates the HPAaxis [20-26].”
Design of Gram-Negative Selective Antimicrobial Peptides
Muhle, S. A., & Tam, J. P. (2001) · Biochemistry · doi:10.1021/bi0100384 · Cited by 81
Endotoxin stress-response in cardiomyocytes: NF-κB activation and tumor necrosis factor-α expression
Wright, G., Singh, I. S., Hasday, J. D., Farrance, I. K. G., Hall, G., Cross, A. S., & Rogers, T. B. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00256.2001 · Cited by 81
“In that regard, mitogen-associated protein kinases, including p38 mitogen-activated kinase and Jun NH2-terminal kinase, have been reported to control TNF- translation in response to LPS (34).”
BackgroundRecent progress in ellagitannin chemistry
Feldman, K. S. (2004) · Phytochemistry · doi:10.1016/j.phytochem.2004.11.015 · Cited by 80
The Many Roles of the Class A Macrophage Scavenger Receptor
Platt, N., Haworth, R., Darley, L., & Gordon, S. (2002) · International review of cytology · doi:10.1016/s0074-7696(01)12002-4 · Cited by 81
Schlegel, R., Krahling, S., Callahan, M. K., & Williamson, P. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400529 · Cited by 80
Selective TRIF-Dependent Signaling by a Synthetic Toll-Like Receptor 4 Agonist
Bowen, W. S., Minns, L. A., Johnson, D. A., Mitchell, T. C., Hutton, M. M., & Evans, J. T. (2012) · Science Signaling · doi:10.1126/scisignal.2001963 · Cited by 79
“We added soluble human lipid-binding protein (LBP) to aid in the proper extraction and presentation of agonists to the TLR4–MD-2 receptor complex under serumfree conditions (32).”
MethodWang, M., Chen, Y., Zhang, Y., Zhang, L., Lu, X., & Chen, Z. (2011) · Cellular and Molecular Immunology · doi:10.1038/cmi.2011.1 · Cited by 79
Peptides with dual mode of action: Killing bacteria and preventing endotoxin-induced sepsis
Brandenburg, K., Heinbockel, L., Correa, W., & Lohner, K. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2016.01.011 · Cited by 79
Rawadi, G., Ramez, V., Lemercier, B., & Roman‐Roman, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1330 · Cited by 79
Tanaka, C., Kamata, H., Takeshita, H., Yagisawa, H., & Hirata, H. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6264 · Cited by 78
Zen, K., Karsan, A., Stempien‐Otero, A., Yee, E., Tupper, J. C., Li, X., Eunson, T., Kay, M. A., Wilson, C. B., Winn, R. K., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28808 · Cited by 79
Implications for the role of lipopolysaccharide in the development of atherosclerosis
Gorabi, A. M., Kiaie, N., Khosrojerdi, A., Jamialahmadi, T., Al‐Rasadi, K., Johnston, T. P., & Sahebkar, A. (2021) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2021.08.015 · Cited by 80
Liu, Q., Chen, T., Chen, G., Li, N., Wang, J., Ma, P., & Cao, X. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.024 · Cited by 78
Effect of CD14 Blockade in Rabbits with Escherichia coli Pneumonia and Sepsis
Frevert, C. W., Matute‐Bello, G., Skerrett, S. J., Goodman, R. B., Kajikawa, O., Sittipunt, C., & Martin, T. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5439 · Cited by 78
“, IL-8), and activation of inducible nitric oxide synthase (7, 8).”
BackgroundKim, S. O., Jing, Q., Hoebe, K. H. N., Beutler, B., Duesbery, N. S., & Han, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209279200 · Cited by 78
The Active Site of Escherichia coli UDP-N-acetylglucosamine Acyltransferase
Wyckoff, T. J. O., & Raetz, C. R. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.27047 · Cited by 78
Quantitative control of MHC class II expression by the transactivator CIITA
Otten, L., Steimle, V., Bontron, S., & Mach, B. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199802)28:02 · Cited by 117
Sachetto, A. T. A., & Mackman, N. (2023) · Thrombosis and Haemostasis · doi:10.1055/a-2091-7006 · Cited by 81
“LPS-binding protein (LBP) present in blood binds to LPS and transfers it to CD14, which is a receptor expressed by monocytes 15 – 19 ( ► Fig.”
BackgroundAlcohol-induced free radicals in mice: Direct toxicants or signaling molecules?
Yin, M., Gäbele, E., Wheeler, M. D., Connor, H. D., Bradford, B. U., Dikalova, A., Rusyn, I., Mason, R. P., & Thurman, R. G. (2001) · Hepatology · doi:10.1053/jhep.2001.28888 · Cited by 77
Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays
Ichiba, T., Teshima, T., Kuick, R. D., Misek, D. E., Liu, C., Takada, Y., Maeda, Y., Reddy, P. R., Williams, D. L., Hanash, S., et al. (2003) · Blood · doi:10.1182/blood-2002-09-2748 · Cited by 77
Immune proteins and their gene expression in the silkworm, Bombyx mori
Yamakawa, M., & Tanaka, H. (1999) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(99)00011-7 · Cited by 77
Differential regulation of gap junctions by proinflammatory mediators in vitro.
Hu, J. Y., & Cotgreave, I. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119410 · Cited by 77
CD14 C(−159)T Polymorphism Is a Risk Factor for Development of Pulmonary Tuberculosis
Rosas-Taraco, A. G., Revol, A., Salinas-Carmona, M. C., Rendón, A., Caballero-Olín, G., & Arce-Mendoza, A. Y. (2007) · The Journal of Infectious Diseases · doi:10.1086/522147 · Cited by 76
“Soluble CD14 (sCD14) is produced by enzymatically cleaved membrane CD14 (mCD14), mediated mainly by phospholipase C, and via secretion of CD 14 [ 11 ].”
BackgroundLee, J., & Park, W. (2015) · Molecules · doi:10.3390/molecules20046888 · Cited by 75
“But, excessive and uncontrolled production of these inflammatory cytokines may lead to serious systemic complications such as microcirculatory dysfunction, tissue damage, and septic shock, which can exact a high mortality [10].”
BackgroundCoumans, A. B. C., Middelanis, J., Garnier, Y., Vaihinger, H., Leib, S. L., von Duering, M. U., Hasaart, T. H. M., Jensen, A., & Berger, R. E. (2003) · Pediatric Research · doi:10.1203/01.pdr.0000059221.40073.82 · Cited by 75
“After binding LPS, the membrane-bound and soluble forms of CD14 promote the activation of myeloid (monocyte/macrophage/polymorphonuclear leukocyte) and nonmyeloid (endothelial/epithelial) cells, respectively (29).”
BackgroundMeng, G., Grabiec, A., Vallon, M., Ebe, B., Hampel, S., Bessler, W. G., Wagner, H., & Kirschning, C. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304766200 · Cited by 75
Wood, S. J., Miller, K. A., & David, S. A. (2004) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207043328832 · Cited by 75
Kedda, M.-A. (2005) · Thorax · doi:10.1136/thx.2004.028449 · Cited by 75
Delayed activation of PPARγ by LPS and IFN‐γ attenuates the oxidative burst in macrophages
VON, K. A., & Brüne, B. (2001) · The FASEB Journal · doi:10.1096/fj.00-0187com · Cited by 75
“membrane receptor (4, 5) as well as toll-like receptors,”
BackgroundDankesreiter, S., Hoess, A., Schneider‐Mergener, J., Wagner, H., & Miethke, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4804 · Cited by 75
Grabiec, A., Meng, G., Fichte, S., Bessler, W. G., Wagner, H., & Kirschning, C. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405311200 · Cited by 74
Blasi, E., Mucci, A., Neglia, R. G., Pezzini, F., Colombari, B., Radzioch, D., Cossarizza, A., Lugli, E., Volpini, G., Giudice, G. D., et al. (2005) · FEMS Immunology & Medical Microbiology · doi:10.1016/j.femsim.2004.12.005 · Cited by 74
“LPS was also included as positive control [41].”
BackgroundInduction of allergic inflammation by interleukin‐18 in experimental animal models
Tsutsui, H., Yoshimoto, T., Hayashi, N., Mizutani, H., & Nakanishi, K. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00205.x · Cited by 74
“organ failure accompanied by sepsis (31).”
Immenschuh, S., Tan, M., & Ramadori, G. P. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80008-7 · Cited by 74
Role of the Gut Microbiome in the Development of Atherosclerotic Cardiovascular Disease
Samarraie, A. A., Pichette, M., & Rousseau, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065420 · Cited by 78
Yang, S., Takahashi, N., Yamashita, T., Sato, N., Takahashi, M., Mogi, M., Uematsu, T., Kobayashi, Y., Nakamichi, Y., Takeda, K., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1956 · Cited by 73
“LPS, an amphiphilic molecule in the outer membrane of Gram-negative bacteria, is involved in bone resorption in inflammatory diseases (10).”
BackgroundEnhanced B‐cell activation mediated by TLR4 and BCR crosstalk
Minguet, S., Dopfer, E. P., Pollmer, C., Freudenberg, M. A., Galanos, C., Reth, M. G., Huber, M., & Schamel, W. W. A. (2008) · European Journal of Immunology · doi:10.1002/eji.200738094 · Cited by 73
Poesen, R., Ramezani, A., Claes, K. J., Augustijns, P., Kuypers, D. R. J., Barrows, I. R., Jagadeesan, M., Evenepoel, P., Meijers, B. K. I., & Raj, D. S. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03100315 · Cited by 73
“CD14 is either membrane-bound with a glycosylphosphatidylinositol anchor or present as a soluble molecule (soluble CD14 [sCD14]) after secretion or enzymatically cleavage (10).”
BackgroundIncreased Levels of Soluble CD14 in Sera of Periodontitis Patients
Hayashi, J., Masaka, T., & Ishikawa, I. (1999) · Infection and Immunity · doi:10.1128/iai.67.1.417-420.1999 · Cited by 75
Kirschning, C. J., Au-Young, J. K., Lamping, N., Reuter, D., Pfeil, D., Seilhamer, J. J., & Schumann, R. R. (1997) · Genomics · doi:10.1006/geno.1997.5030 · Cited by 73
Molecular Mechanisms of Innate Immunity
Ulevitch, R. J. (2000) · Immunologic Research · doi:10.1385/ir:21:2-3:49 · Cited by 73
Self-citationHeinzelmann, M., Mercer-Jones, M. A., Flodgaard, H. J., & Miller, F. N. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5530 · Cited by 73
Guntupalli, K. K., Dean, N. C., Morris, P. E., Bandi, V., Margolis, B. D., Rivers, E., Levy, M. M., Lodato, R. F., Ismail, P. M., Reese, A., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182741551 · Cited by 72
Aggregation Behavior of an Ultra-Pure Lipopolysaccharide that Stimulates TLR-4 Receptors
Sasaki, H., & White, S. H. (2008) · Biophysical Journal · doi:10.1529/biophysj.108.129197 · Cited by 72
“This raises the possibility that the critical aggregation concentration in culture medium could be different due to the binding of LPS to serum components such as LBP, sCD14, and lipoproteins (5,41).”
BackgroundShibazaki, M., Kawabata, Y., Yokochi, T., Nishida, A., Takada, H., & Endo, Y. (1999) · Infection and Immunity · doi:10.1128/iai.67.10.5186-5191.1999 · Cited by 72
Wijayanti, N., Huber, S., Samoylenko, A., Kietzmann, T., & Immenschuh, S. (2004) · Antioxidants and Redox Signaling · doi:10.1089/ars.2004.6.802 · Cited by 71
Antiendotoxin Strategies for the Prevention and Treatment of Septic Shock
Opal, S. M., & Yu, R. L. (1998) · Drugs · doi:10.2165/00003495-199855040-00002 · Cited by 71
Understanding the mechanism of action of bacterial superantigens from a decade of research
Lavoie, P. M., Thibodeau, J., Erard, F., & Sékaly, R. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01297.x · Cited by 71
The wild-derived inbred mouse strain SPRET/Ei is resistant to LPS and defective in IFN-β production
Mahieu, T., Park, J. M., Revets, H., Pasche, B., Lengeling, A., Staelens, J., Wullaert, A., Vanlaere, I., Hochepied, T., van Roy, F., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510874103 · Cited by 70
Dixon, G. L. J., Newton, P., Chain, B., Katz, D. R., Andersen, S. R., Wong, S. Y. C., van der Ley, P., Klein, N. J., & Callard, R. E. (2001) · Infection and Immunity · doi:10.1128/iai.69.7.4351-4357.2001 · Cited by 70
“host inflammatory responses (40) and was considered to be the”
BackgroundEndotoxin opens the Toll gates to innate immunity
Ulevitch, R. J. (1999) · Nature Medicine · doi:10.1038/5504 · Cited by 70
Self-citationTominaga, K., Saito, S., Matsuura, M., & Nakano, M. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(99)00037-3 · Cited by 70
Wang, M., Zhang, Y., Chen, Y., Zhang, L., Lu, X., & Chen, Z. (2011) · BMC Immunology · doi:10.1186/1471-2172-12-1 · Cited by 69
“LPS-activated cells sometimes induce microcirculatory dysfunction as well as inflammatory changes, which cause injury to various tissues, circulatory failure, and occasionally death [36-38].”
BackgroundToll gates for pathogen selection
Ulevitch, R. J. (1999) · Nature · doi:10.1038/44490 · Cited by 69
Self-citationToll-like receptor signalling and the clinical benefits that lie within
Verstak, B., Hertzog, P. J., & Mansell, A. S. (2007) · Inflammation Research · doi:10.1007/s00011-007-6093-7 · Cited by 69
CD14-independent activation of cardiomyocyte signal transduction by bacterial endotoxin
Cowan, D. B., Poutias, D., del Nido, P. J., & McGowan, F. X. J. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.2.h619 · Cited by 69
“, endothelial, epithelial, and smooth muscle cells) (31, 40, 54).”
BackgroundInfluentialGenetic Control of Experimental Lyme Arthritis in the Absence of Specific Immunity
Brown, C. R., & Reiner, S. L. (1999) · Infection and Immunity · doi:10.1128/.67.4.1967-1973.1999 · Cited by 67
Freudenberg, M. A., Merlin, T., Gumenscheimer, M., Kalis, C., Landmann, R. M., & Galanos, C. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01481-2 · Cited by 68
Matute‐Bello, G., Frevert, C. W., Liles, W. C., Nakamura, M., RUZINSKI, J. T., Ballman, K. K., Wong, V. A., Vathanaprida, C., & Martin, T. R. (2001) · Infection and Immunity · doi:10.1128/iai.69.9.5768-5776.2001 · Cited by 68
“For example, E. coli infection can result in PMN recruitment thru activation of CD14dependent pathways, with the generation of endogenous chemoattractants, such as IL-8 (4, 28).”
BackgroundInfluentialDonati, M., Berglundh, T., Hytönen, A.-M., Hahn‐Zoric, M., Hanson, L., & Padyukov, L. (2005) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2005.00697.x · Cited by 68
Rieser, C., Papesh, C., Herold, M., Böck, G., Ramoner, R. E., Klocker, H., Bartsch, G. H., & Thurnher, M. (1998) · Blood · doi:10.1182/blood.v91.9.3112 · Cited by 66
Structural Regions of MD-2 That Determine the Agonist-Antagonist Activity of Lipid IVa
Muroi, M., & Tanamoto, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509193200 · Cited by 67
Jialal, I., Devaraj, S., Bettaieb, A., Haj, F. G., & ADAMS-HUET, B. A. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.814 · Cited by 67
Kirschning, C., & Bauer, S. (2001) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00128 · Cited by 82
Fischer, C., Page, S., Weber, M., Eisele, T., Neumeier, D., & Brand, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24625 · Cited by 67
Sheir, S. K., & Handy, R. D. (2010) · Archives of Environmental Contamination and Toxicology · doi:10.1007/s00244-010-9502-9 · Cited by 66
“Lipopolysaccharides (LPSs) are found on the external membranes of Gram-negative bacteria and are known to stimulate immune responses in eukaryote organisms by several methods, including the activation of signal transduction pathways in macrophages (Ulevitch and Tobias 1995).”
BackgroundKim, G., Han, M.-G., Song, Y., Shin, B., Shin, Y., Lee, H.-J., Moon, D., Lee, C.-M., Kwak, J., Bae, Y., et al. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.1656 · Cited by 66
Xian, J.-A., Wang, A., Tian, J., Huang, J., Ye, C., Wang, W., & Sun, R. (2009) · Aquaculture · doi:10.1016/j.aquaculture.2009.10.008 · Cited by 67
Osteoclast activation in inflammatory periodontal diseases
Wiebe, S. H., Hafezi, M., Sandhu, H., Sims, S. M., & Dixon, S. J. (1996) · Oral Diseases · doi:10.1111/j.1601-0825.1996.tb00218.x · Cited by 66
Acıoğlu, Ç., Heary, R. F., & Elkabes, S. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.02.016 · Cited by 67
“For example, several receptor complexes have been described for TLR4 (Miyake, 2004; Shimazu et al., 1999; Ulevitch and Tobias, 1995).”
Liu, C., Yang, N., Song, Y., Wang, L., Zi, J., Zhang, S., Dunkin, D., Busse, P. J., Weir, D., Tversky, J. R., et al. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.05.018 · Cited by 65
“Increased levels of phosphorylated- IκB-α (p-IκBα) protein and p65 in cytosol and nuclear p-p65 indicate heightened NF-κB activation (Ulevitch and Tobias, 1995).”
BackgroundGou, Z., Liu, R., Zhao, G., Zheng, M., Li, P., Wang, H., Zhu, Y., Chen, J., & Wen, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033627 · Cited by 65
“[6,7,8].”
Choi, S., Nguyen, V. T., Tae, N., Lee, S.-H., Ryoo, S., Min, B.-S., & Lee, J. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.09.007 · Cited by 65
Voronov, E., Apte, R. N., & Sofer, S. (1999) · Journal of Venomous Animals and Toxins · doi:10.1590/s0104-79301999000100002 · Cited by 65
Caspase-7 deficiency protects from endotoxin-induced lymphocyte apoptosis and improves survival
Lamkanfi, M., Moreira, L. O., Makena, P. S., Spierings, D. C. J., Boyd, K. L., Murray, P. J., Green, D. R., & Kanneganti, T. (2009) · Blood · doi:10.1182/blood-2008-09-178038 · Cited by 65
“These cytokines and chemokines are believed to be important mediators of organ injury in endotoxic shock.(20,21,23) Therefore, we addressed whether caspase-7 mediates lymphocyte apoptosis indirectly by”
Harvey, H. A., Post, D. M. B., & Apicella, M. A. (2002) · Infection and Immunity · doi:10.1128/iai.70.10.5808-5815.2002 · Cited by 66
“Similar to other pathogenic bacterial endotoxins (4, 22, 25, 29, 30), gonococcal lipooligosaccharide (LOS) is believed to play a role in the inflammatory response (12, 24, 27).”
BackgroundLin, H., Tang, C., Chen, J.-H., Chuang, J., Huang, S.-M., Tan, T., Lai, C., & Lu, D. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22489 · Cited by 66
“These inflammatory molecules are the major cause of the various signs and symptoms that occur during bacterial infection, including fever, inflammation, and acute phase responses (Bone, 1994; Ulevitch and Tobias, 1995; Dziarski et al., 2000).”
BackgroundJanot, L., Sécher, T., Torres, D., Maillet, I., Pfeilschifter, J. M., Quesniaux, V. F. J., Landmann, R. M., Ryffel, B., & Erard, F. (2008) · The Journal of Infectious Diseases · doi:10.1086/588815 · Cited by 65
“of proinflammatory cytokines [7, 8].”
van Oosten, M., van de Bilt, E., van Berkel, T. J. C., & Kuiper, J. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5107-5112.1998 · Cited by 64
Metadata
- Authors
- Ulevitch, R. J., & Tobias, P. S.
- Affiliations
- Scripps Research Institute (US)
- ORCID
- Ulevitch, R J
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 1995-04
- Volume
- 13
- Issue
- 1
- Pages
- 437-457
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- OpenAlex
- W2113828544
- Cited by
- 1,442
- References
- 36
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 8 · 2023: 11 · 2022: 13 · 2021: 25 · 2020: 23 · 2019: 21 · 2018: 22 · 2017: 24 · 2016: 37 · 2015: 29 · 2014: 39 · 2013: 43 · 2012: 38
- FWCI
- 20.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (GM28485, GM3769)
- National Institute of Allergy and Infectious Diseases (AI 15136, R01AI015136)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- lipopolysaccharide, endotoxin, LPS receptor, CD14, LPS-binding protein, septic shock, myeloid cells, intracellular signaling, transmembrane proteins, pro-inflammatory mediators
- MeSH terms
- Lipopolysaccharide-Binding Protein, Acute-Phase Proteins, Amino Acid Sequence, Animals, Carbohydrate Sequence, Carrier Proteins, Humans, Lipopolysaccharides, Membrane Glycoproteins, Models, Biological, Molecular Sequence Data, Receptors, Immunologic, Shock, Septic, Antigens, Differentiation, Myelomonocytic, Molecular Structure, Signal Transduction, Antigens, CD, Calcium-Calmodulin-Dependent Protein Kinases, Lipopolysaccharide Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review